IPG Investment Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1602237 SAN DIEGO, CA

Position in GILD

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$232,747

+$15,678 QoQ

Shares Held

1,670

-28.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

3 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

IPG Investment Advisors LLC holds $3,150,601 across 3 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,122	$2,545,190
2	MRK	Merck & Co., Inc.	2,702	$347,207
3	NVO	Novo Nordisk A S	5,386	$258,204

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$232,747	1,670	-28.9%	Shares	Sole	2026-05-12
2024-12-31	$217,069	2,350	-21.4%	Shares	Sole	2025-02-12
2020-03-31	$223,532	2,990	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.